| DRAVP ID | Name | Sequence | Target Organism | Pubmed/Patent ID |
|---|---|---|---|---|
| DRAVPe02608 | 99-116 | SPRGSRPSWGPTDPRRRS | HCV | 22452666 |
| DRAVPe02609 | 146-160 | SMTDFYHSKRRLIFS | HCV | 22452666 |
| DRAVPe02610 | 22-39 | VKFPGGGQIVGGVYLLPR | HCV | 22452666 |
| DRAVPe02611 | 321-335 | AFKQSPPAIPALGTN | HCV | 22452666 |
| DRAVPe02612 | 29-46 | QIVGGVYLLPRRGPRLGV | HCV | 22452666 |
| DRAVPe02613 | 155-172 | VRVLEDGVNYATGNLPGC | HCV | 22452666 |
| DRAVPe02614 | 113-130 | RRRSRNLGKVIDTLTCGF | HCV | 22452666 |
| DRAVPe02615 | 43101 | MSTNPKPQRKTKRNTNRR | HCV | 22452666 |
| DRAVPe02616 | 150-164 | FYHSKRRLIFSKRKP | HCV | 22452666 |
| DRAVPe02617 | 324-338 | QSPPAIPALGTNVKK | HCV | 22452666 |
| DRAVPe02618 | 43-60 | RLGVRATRKTSERSQPRG | HCV | 22452666 |
| DRAVPe02619 | 2402-2416 | DGSWSTVSSGADTED | HCV | 22452666 |
| DRAVPe02620 | 148-165 | ARALAHGVRVLEDGVNYA | HCV | 22452666 |
| DRAVPe02621 | 134-151 | MGYIPLVGAPLGGAARAL | HCV | 22452666 |
| DRAVPe02622 | 57-74 | QPRGRRQPIPKARRPEGR | HCV | 22452666 |
| DRAVPe02623 | 2395-2412 | PGDPDLSDGSWSTVSSGA | HCV | 22452666 |
| DRAVPe02624 | 64-81 | PIPKARRPEGRTWAQPGY | HCV | 22452666 |
| DRAVPe02625 | 36-53 | LLPRRGPRLGVRATRKTS | HCV | 22452666 |
| DRAVPe02626 | 71-88 | PEGRTWAQPGYPWPLYGN | HCV | 22452666 |
| DRAVPe02627 | 50-67 | RKTSERSQPRGRRQPIPK | HCV | 22452666 |
| DRAVPe02628 | 120-137 | GKVIDTLTCGFADLMGYI | HCV | 22452666 |
| DRAVPe02629 | 15-32 | TNRRPQDVKFPGGGQIVG | HCV | 22452666 |
| DRAVPe02651 | MrIA-SL | CGYKLC | DENV 2 | 22780881 |
| DRAVPe02652 | Inhibitor 1 | CGYGLC | DENV 2 | 22780881 |
| DRAVPe02653 | Inhibitor 2 | CGYGLC | DENV 2 | 22780881 |
| DRAVPe02654 | Inhibitor 3 | CGYKGC | DENV 2 | 22780881 |
| DRAVPe02655 | Inhibitor 4 | CGYKRC | DENV 2 | 22780881 |
| DRAVPe02656 | Inhibitor 5 | CGKRRC | DENV 2 | 22780881 |
| DRAVPe02657 | Inhibitor 6 | CGKRKLC | DENV 2 | 22780881 |
| DRAVPe02658 | Inhibitor 7 | CGKRKSC | DENV 2 | 22780881 |